期刊文献+

灭活全菌neuB1失活空肠弯曲菌突变株口服免疫BALB/c小鼠的实验研究

Oral immunization of BALB/c mice with a Campylobacter jejuni mutant strain with deleting neuB1 gene
下载PDF
导出
摘要 目的探讨neuB1失活CjO:19突变株灭活全菌苗的免疫原性及其对抗Cj野生株攻击的免疫保护性。方法以突变株灭活菌体,经口途径以不同剂量免疫BALB/c小鼠,ELISA法检测小鼠肠腔灌洗液和血液中的抗体应答;并以5×10^9CFU野生株进行攻击,计算疾病指数。结果免疫后7d肠灌洗液中的抗Cj特异性sIgA和21d血清中特异性IgG及IgA滴度均显著增高;免疫组的疾病指数分别由0.83降至0.31~0.36,保护率为57%~63%。结论突变株灭活全菌苗经口免疫,能诱导动物产生显著有效的体液免疫应答,证实突变株灭活全菌苗具有显著的免疫原性;突变株灭活全菌苗经口服免疫,能有效保护免疫小鼠免受野生株的攻击,基于该突变株良好的免疫活性且无分子模拟所致的神经毒性,有望成为理想的Cj全菌疫苗候选者。 To explore the immunogenicity of Campylobacter jejuni (Cj) O: 19 strain with deleting neuB1 gene, and to investigate its protection against challenge by wild Cj O: 19 strain in BALB/c mice. Inactivated whole cell vaccine prepared with the mutant Cj O: 19 strain was used to immunize BALB/c mice orally with different doses, and SIgA in intestinal lavage, and IgG and IgA in serum of the immunized mice were measured by ELISA respectively. Twenty-six days after immunization, massive wild Cj strain in S × 10^9CFU were intranasally taken in mice, then the animals were monitored for illness index. It was found thet the effective humoral immune response was predominantly induced. Titers of Cj-specific slgA in intestinal lavage on day 7, the Cj-specific IgG and IgA in serum day 21 after immunization were significantly increased; Illness index was decreased from 0. 83 to 0. 31 -0.36 in the immunized mice, and corresponding protective rates against disease symptoms were 57%-63 %. In conclusions,oral immunization with the Cam pylobacter jejuni mutant strain with deleting neuB1 gene induce the responses in sera and intestinal lavage and offer an effective protection against the invading wild Cj strain in mice.
出处 《中国人兽共患病学报》 CAS CSCD 北大核心 2007年第1期59-62,共4页 Chinese Journal of Zoonoses
基金 国家自然科学基金资助项目(30170990)
关键词 弯曲杆菌 空肠 neuB1 全菌苗 Cam pylobacter jejuni neuB1 gene whole-cell vaccine
  • 相关文献

参考文献17

  • 1Haberberger RL Jr, Walker RI. Prospects and problems for development of a vaccine against diarrhea caused by Campylobacter [J]. Vaccine Res, 1994, 3:15-22.
  • 2Scott DA. Vaccines against Campylobacterjejuni [J]. J Infect Dis, 1997,176(Suppl 2): S183-188.
  • 3Crushell E, Sinead H, Farhana S, et al. Enteric Campylobacter: purging its secrets[J]. Pediatr Res, 2004,55(1): 3-12.
  • 4Rees JH, Soudain SF, Gregson NA, et al. Campylobacter jejuni infection and Guillain-Barr syndrome [J]. N Engl J Med, 1995,333 : 1374-1379.
  • 5刘超,蔡方成,席孝庄,丁波,翟奇,张晓萍,银平.空肠弯曲菌感染致人畜共患的周围神经病[J].中华儿科杂志,2000,38(1):13-15. 被引量:7
  • 6McCarthy N, Giesecke J. Incidence of Guillain-Barré syndrome following infection with Campylobacterjejuni. Am J Epidemiol, 2001,153(6) :610-614.
  • 7Nachamkin I, Allos BM, HOT. Campylobacter Species and Guillain-Barr Syndrome [J]. Clin Microbiol Rev, 1998,11 (3) : 555 567.
  • 8Guerry P, Pope P, Burr D, et al. Development and characterization of recA mutants of Campylobacterjejuni for inclusion in attenuated vaccines[J]. Infect Immun, 1994, 62(2) :426-432.
  • 9Baqar S, Applebee LA, Bourgeois AL. Immunogenicity and protective efficacy of a prototype Campylobacter killed whole-cell vaccine in mice[J]. Infect Immun, 1995,63:3731-3735.
  • 10Lee LH, Burg 3rd E, Baqar S, et al. Recombinant flagellin subunit vaccine against Campylobacter jejuni [J]. Infect Immun 1999,67(11) :5799-5805.

二级参考文献40

  • 1张杰敏,蔡方成.不同菌型空肠弯曲菌免疫诱发大鼠变态反应性周围神经病的对比研究[J].中华儿科杂志,2001,39(1):24-27. 被引量:6
  • 2陈志新,吕德生,万绍平,王伯伦,杨彩萍.儿童空肠弯曲菌感染的流行病学研究[J].中华预防医学杂志,1995,29(3):144-146. 被引量:11
  • 3J撒姆布鲁克 EF弗里奇 T罗尼阿蒂斯等.分子克隆实验指南:第二版[M].北京:科学出版社,1993.34-55.
  • 4Pei ZC, Burucoa B, C, rignon S, et al. Mutation in the peb1A locus of Campylobacter jejuni reduces interactions with epithelial cells and intestinal colonization of mice. Infect Immun, 1998, 66: 938-943.
  • 5Parkhill J, Wren BW, Mungall K, et al. The gemme sequaace of the food-borne pathogen reveals hypervariable sequences. Nature, 2000, 403:665-668.
  • 6Prendergast MM, Lastovica AJ, Moran AP. Lipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 ganglioside. Infect Immun, 1998, 66:3649-3755.
  • 7Ho TW, McKhann GM, Griffin JW. Human autoimmune neuropathies. Annu Rev Neurosci, 1998, 21:187-226.
  • 8Goodyear CS, O′Hanlon GM, Plomp JJ, et al. Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations. J Clin Invest, 1999,104: 697-708.
  • 9Neisser A, Schwerer B, Bernheimer H, et al. Ganglioside-induced antiganglioside antibodies from a neuropathy patient cross-react with lipopolysaccharides of Campylobacter associated with Guillain-Barré syndrome. J Neuroimmunol, 2000,102:85-88.
  • 10Nachamkin I, Allos BM, HO T. Campylobacter species and Guillain-Barré Syndrome. Clin Microbiol Rev, 1998,11:555-567.

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部